Evidence map›Paper›PMID 31803232›Full record

ArticleFrontiers in genetics2019

Comprehensive Assessment of

Logan C Walker, Vanessa Lilian Lattimore, Anders Kvist, Petra Kleiblova, Petra Zemankova, Lucy de Jong, George A R Wiggins, Christopher Hakkaart, Simone L Cree, Raquel Behar and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Saturation genome editing ofmedRxiv : the preprint server for health sciences · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Breast Cancer Predisposition Genes and Synthetic Lethality.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 6 countries.

Logan C WalkerDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Vanessa Lilian LattimoreDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Anders KvistDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Petra KleiblovaInstitute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.
Petra ZemankovaInstitute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czechia.
Lucy de JongDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
George A R WigginsDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Christopher HakkaartDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Simone L CreeDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Raquel BeharMolecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
Claude HoudayerDepartment of Genetics, F76000 and Normandy University, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, Rouen, France.
kConFab InvestigatorsSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
Michael T ParsonsDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Martin A KennedyDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Amanda B SpurdleDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Miguel de la HoyaMolecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
University of Otago · NZCharles University · CZInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESQIMR Berghofer Medical Research Institute · AUInserm · FRLund University · SEThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACMGbreast cancermRNA splicingnanopore sequencingRNAseq analysisvariant classification

Identifiers

PMID31803232
PMCPMC6877745
OpenAlexW2989899583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.